These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2938089)

  • 1. [Reduction of hypoglycemia in 10 diabetic patients treated with continuous subcutaneous infusion of insulin].
    Leblanc H; Obadia G; Passa P
    Presse Med; 1986 Mar; 15(10):463-6. PubMed ID: 2938089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
    Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.
    Lager I; Attvall S; Blohmé G; Smith U
    Diabet Med; 1986; 3(4):322-5. PubMed ID: 2949919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
    Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
    Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy.
    Bendtson I; Kverneland A; Pramming S; Binder C
    Acta Med Scand; 1988; 223(6):543-8. PubMed ID: 3291561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycaemia and cardiovascular disease in Type 1 Diabetes. Results from the Catalan National Public Health registry on insulin pump therapy.
    Giménez M; López JJ; Castell C; Conget I
    Diabetes Res Clin Pract; 2012 May; 96(2):e23-5. PubMed ID: 22306058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics.
    Felsing W; Bibergeil H; Menzel R; Albrecht G; Felsing U; Dabels J; Reichel G; Lüder C
    Exp Clin Endocrinol; 1984 Apr; 83(2):136-42. PubMed ID: 6373315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
    Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
    Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous subcutaneous insulin infusion: long-term treatment in an unselected group of insulin-dependent diabetics].
    Waldhäusl W; Freyler H; Bratusch-Marrain P; Vierhapper H; Bruneder H
    Dtsch Med Wochenschr; 1983 Apr; 108(15):570-7. PubMed ID: 6404620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.